Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer - ER+, HER2 -

Explore clinical trials studying Breast Cancer - ER+, HER2 -. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer - ER+, HER2 - trial results

Completed

Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid Tumours

NCT02260661

Conditions
Advanced Solid Malignancies, Breast Cancer - ER+, HER2 -, Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation, +6 more
Locations
  • Research Site Denver, Colorado, United States
  • Research Site Greenville, South Carolina, United States
  • Research Site Nashville, Tennessee, United States
  • Research Site Houston, Texas, United States
View Trial Details

Related conditions